THE KING OF IODINE CHEMISTRY

Brochure

+91-7507534567 / 7045002222

contact@samratpharmachem.in

Office

Factory

Home
About Us
Products
Investors
Contact Us

26 May 2022, 8:30:01 PM IST

Business Synopsis

Business Overview

Timeline & History

Board of Directors

Mission Vision & Philosophy

Product & Quality Policy

Governance Policies

Infrastructure Gallery

Plant & Machinery

Laboratory Equipments

Effluent Treatment Plant

Registration Details

Achievements

Careers

Results & Reports

Quarterly Results

Share Holders Information

Share Holding Pattern

Share Transfer Agent

Investor Policies

Corporate Governance

Board Committees

Corporate Governance Report

Code of Conduct

Statutory Communications

Statutory Communications

Home
Statutory Communications

2021-22

2020-21

2019-20

2018-19

2017-18

2021-22

Certificate under Regulation 74(5)-2122-Q3

Reconciliation of share capital audit FY2122-Q3

Reconciliation of share capital audit FY2122-Q3 (XBRL)

News Paper Publication of Results-FY2122-Q1

Certificate under Regulation 74(5)-2122-Q1

Reconciliation of Share Capital Audit-2122-Q1 Manual

Reconciliation of share capital audit_FY2122_Q1_XBRL

Bse_Clarification_on_Price_Movement_27042021

Certificate under Regulation 74(5) 2021 – 22 – Q2

Reconciliation of share capital audit FY2122-Q2 (Manual)

Reconciliation of share capital audit FY2122-Q2 (XBRL)

Intimation to BSE for appointment of Cost Auditor

Bse_Clarification_on_Price_Movement_28122021

Notice of Closure of Trading Window – Q4_FY2122

Notice of Board Meeting for AFR – Q4_FY2122

2020-21

Reconciliation of share capital audit_19-20_Q3

Reconciliation of Share Report Q4 (2019-2020)

Publication of Results_Q1_FY2021

Regulation 7(3)

Reg 40(9),(10)_Half yearly_Sep’20

Certificate under Regulation 74(5)-2021-Q3

Publication of Results -FY2021-Q3

Related Party Disclosure – Half Yearly – Sec 23(9)_2021_Q2

BSE_Annual Report

BSE-Notice of AGM

Newspaper Publication – Book Closure Notice

2019-20

Notice of Board Meeting

Notice of Closure of Trading Window – Q1 FY1920

Newspaper Publication – Results Extract

Notice, Attendance Slip, Proxy Form

Announcement of Results Q2

Scrutiner Report

Notice of Closure of Trading Window – Q2 FY1920

Notice of Board Meeting for UFR

Reconciliation of Share Capital Audit-Q1-(30-06-2019)

Reconciliation of share capital audit-Q2-(30-09-2019)

Reg 40(9),(10) Half Yearly (30-09-2019)

Compliance Certificate – 7(3) – (30-09-2019)

2018-19

Notice of 26 AGM & Book Closure

AGM Notice, Attendance Slip & Proxy Form

Publication Results – June 30, 2018 Investor Complaints Q1

Notice of Board Meeting – 30-06-2018

Reconciliation of share capital audit-18-19-Q1

Reco Share Capital Audit 1819-Q1 MR

Notice of Book Closure -FY1819-Q2

Reconciliation of share capital audit-Q2-1819

Notice of Board Meeting -FY1819-Q2

Notice of Trading Window FY1819 – Q3

Reg(40)9(10)-Compliance Certificate Q3

Reconciliation of share capital audit Q3

Newspaper Publication – of Board Meeting – FY1819 Q3

Notice of Board Meeting for AFR

Intimation Trading Window

Reconciliation of share capital audit-(18-19)-Q4

Reg 40(9),(10) Compliance Certificate

2017-18

Notice of Board Meeting

Investor Complaints

Reconsilation of share capital audit

Newspaper Publication

Investor Grievances

Reconciliation of share capital audit Q3 2017-18

Notice of Board Meeting & Closure of Trading Window Q3 2017-18

Notice Of Board Meeting & Closure of Trading Window – Q2 FY 2017-18

Publication of Notice of Board Meeting in newspapers

Declaration with respect to Audit Report with unmodified option for the Financial year ended March 31, 2017

Closure of Register of Members & Share Transfer Books & 25th Annual General Meeting of the Company

Intimation of Postponement of BOD for Approval of UFR and closure of trading window for the Quarter Ended June 30,2017

Notice of 25 th AGM, Attendance Slip with Proxy Form

Statement of Investor Complaints For The Quarter Ended June, 2017 – Reg 13(3)

Reconciliation of Share Capital Audit – Q1 (FY:2017-18)

Notice of Board Meeting & Closure of Trading Window-Q1 (FY:2017-18)

Financial Results for March 31, 2017

Compliance Certificate Reg. 7(3) – (RTA & Compliance Officer) for the period ended March, 2017

Compliance Certificate Under Regulation 40(9), (10) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015, for the Half Year Ended March 31, 2017

Statement Of Investor Complaints For The Quarter Ended March, 2017 – Reg 13(3)

Notice of Board Meeting & Trading Window Closure – Q4 (FY: 2016-17)

Notice of 24 th AGM, Addendum, Attendance Slip with Proxy Form & Polling Paper

Notice of 24th AGM & Book Closure

Publication Addendum

Investors Relation

Notices
Annual Reports
Investor Policies

Latest News

Closure of Trading Window
Notice of Board Meeting
BSE Clarification

Contact Us

701/702, Business Square, M. A. Road, Andheri (West), Mumbai – 400058, India.

+91-22-26701050 / 1 / 2 / 3

+91-7507534567 / 8760345678

contact@samratpharmachem.in

www.samratpharmachem.com

Contents on the website are correctCopyright 2022 © Samrat Pharmachem Limited

Business Synopsis

Business Overview

Timeline & History

Board of Directors

Mission Vision & Philosophy

Product & Quality Policy

Governance Policies

Infrastructure Gallery

Plant & Machinery

Laboratory Equipments

Effluent Treatment Plant

Registration Details

Achievements

Careers

Results & Reports

Quarterly Results

Share Holders Information

Share Holding Pattern

Share Transfer Agent

Investor Policies

Corporate Governance

Board Committees

Corporate Governance Report

Code of Conduct

Statutory Communications